Pediatric cancer AI predictions are changing the landscape of how we assess and manage cancer in children, particularly in the realm of gliomas.A groundbreaking study conducted by researchers at Harvard has unveiled an AI tool capable of predicting the risk of cancer relapse with remarkable accuracy, far surpassing traditional methods.